Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.

S A Charhon, P D Delmas, L Malaval

    The Journal of Clinical Endocrinology and Metabolism
    |October 1, 1986
    PubMed
    Summary

    Serum bone Gla-protein (S-BGP) is a valuable marker for assessing bone remodeling in hemodialysis patients. It better distinguishes high-turnover from low-turnover renal osteodystrophy than alkaline phosphatase.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Deletion of osteopontin or bone sialoprotein induces opposite bone responses to mechanical stimulation in mice.

    Bone reports·2022
    Same author

    Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover.

    Bone·2018
    Same author

    Validation of an in vitro 3D bone culture model with perfused and mechanically stressed ceramic scaffold.

    European cells & materials·2015
    Same author

    New insight into the bony labyrinth: a microcomputed tomography study.

    Auris, nasus, larynx·2009
    Same author

    Role of the small integrin-binding ligand N-linked glycoprotein (SIBLING), bone sialoprotein (BSP) in bone development and remodeling.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
    Same author

    Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions.

    Journal of cellular physiology·2008

    Area of Science:

    • Nephrology
    • Biochemistry
    • Bone Metabolism

    Background:

    • Chronic hemodialysis patients often develop renal osteodystrophy.
    • Assessing bone turnover in these patients is crucial for management.
    • Existing biochemical markers have limitations in differentiating bone disease subtypes.

    Purpose of the Study:

    • To evaluate serum bone Gla-protein (S-BGP) as a marker for bone remodeling in hemodialysis patients.
    • To correlate S-BGP levels with bone histomorphometry and other biochemical parameters.
    • To assess S-BGP's ability to differentiate between high-turnover (HT-ROD) and low-turnover (LT-ROD) renal osteodystrophy.

    Main Methods:

    • Measured serum bone Gla-protein (S-BGP), alkaline phosphatase (S-AP), and immunoreactive PTH (S-iPTH) in 42 hemodialysis patients.

    Related Experiment Videos

  • Performed tetracycline-labeled transiliac bone biopsies for histomorphometric analysis.
  • Correlated biochemical markers with bone histomorphometric parameters.

    • Main Results:

    • S-BGP levels were markedly increased in hemodialysis patients compared to normal subjects.
    • S-BGP significantly correlated with S-AP and S-iPTH.
    • S-BGP was significantly higher in HT-ROD patients than in LT-ROD patients.
    • S-BGP correlated strongly with cellular and dynamic bone formation parameters.
    • S-BGP showed a negative correlation with bone aluminum staining.
    • S-BGP provided better discrimination between LT-ROD and HT-ROD than S-AP.

    Conclusions:

    • Serum bone Gla-protein (S-BGP) is a valuable marker for evaluating bone remodeling in hemodialysis patients.
    • S-BGP specifically reflects the bone formation rate at the tissue level.
    • While useful for differentiating ROD subtypes, S-BGP did not distinguish osteomalacia within the LT-ROD group.